CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 4, July/August 2014
AFRICA
189
109
: 2411–2416.
4.
Cury RC, Shash K, Nagurney JT,
et al
. Cardiac magnetic resonance
with T2-weighted imaging improves detection of patients with acute
coronary syndrome in the emergency department.
Circulation
2008;
118
: 837–844.
5.
Lockie T, Nagel E, Redwood S, Plein S. Use of cardiovascular magnetic
resonance in acute coronary syndromes.
Circulation
2009;
119
: 1671–
1681.
6.
Fuernau G, Eitel I, Franke V,
et al
. Myocardium at risk in ST-segment
elevation myocardial infarction.
J Am Coll Cardiol Img
2011;
4
: 967–976.
7.
Graham MM, Faris PD, Ghali WA,
et al
. for the APPROACH investi-
gators. Validation of three myocardial jeopardy scores in a population-
based cardiac catheterization cohort
. Am Heart J
2001;
142
: 254–261.
8.
Ishida M, Kato S, Sakuma H. Cardiac MRI in ischemic heart disease.
Circ J
2009;
73
: 1577–1588.
9.
Kwon DH, Halley CM, Carrigan TP,
et al
. Extent of left ventricular
scar predicts outcomes in ischemic cardiomyopathy patients with signifi-
cantly reduced systolic function: a delayed hyperenhancement cardiac
magnetic resonance study.
J Am Coll Cardiol Img
2009;
2
: 34–44.
10. Cheong BY, Muthupillai R, Wilson JM,
et al.
Prognostic significance
of delayed-enhancement magnetic resonance imaging: survival of 857
patients with and without left ventricular dysfunction.
Circulation
2009;
120
: 2069–2076.
11. Boyé P, Abdel-Aty H, Zacharzowsky U,
et al
. Prediction of life-threat-
ening arrhythmic events in patients with chronic myocardial infarction
by contrast-enhanced CMR.
J Am Coll Cardiol Img
2011;
4
: 871–879.
12. Desjardins B, Crawford T, Good E,
et al
. Infarct architecture and
characteristics on delayed enhanced magnetic resonance imaging and
electro-anatomic mapping in patients with post-infarction ventricular
arrhythmia.
Heart Rhythm
2009;
6
: 644–651.
13. Kelle S, Roes SD, Klein C,
et al
. Prognostic value of myocardial infarct
size and contractile reserve using magnetic resonance imaging.
J Am
Coll Cardiol
2009;
54
: 1770–1777.
14. Beek AM, Kühl HP, Bondarenko O,
et al
. Delayed contrast-enhanced
magnetic resonance imaging for the prediction of regional functional
improvement after acute myocardial infarction.
J Am Coll Cardiol
2003;
42
: 895–901.
15. Rezkalla SH, Kloner RA. No-reflow phenomenon.
Circulation
2002;
105
: 656–662.
16. Friedrich MG. Tissue characterization of acute myocardial infarction
and myocarditis by cardiac magnetic resonance.
J Am Coll Cardiol Img
2008;
1
: 652–662.
17. Bernhardt P, Levenson B, Albrecht A, Engels T, Strohm O. Detection of
cardiac small vessel disease by adenosine-stress magnetic resonance.
Int
J Cardiol
2007;
121
: 261–266.
18. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos
RC. Diagnostic performance of of stress cardiac magnetic resonance
imaging in the detection of coronary artery disease.
J Am Coll Cardiol
2007;
50
: 1343–1353.
19. Klem I, Heitner JF, Shah DJ,
et al
. Improved detection of coronary
artery disease by stress perfusion cardiovascular magnetic resonance
with the use of delayed enhancement infarction imaging.
J Am Coll
Cardiol
2006;
47
(8): 1630–1638.
20. Schwitter J, Wacker CM, Wilke N,
et al.
MR-IMPACT II: Magnetic
resonance imaging for myocardial perfusion assessment in coronary
artery disease trial: perfusion-cardiac magnetic resonance vs. single-
photon emission computed tomography for the detection of coronary
artery disease: a comparative multicenter, multivendor trial.
Eur Heart
J
2013;
34
(10): 775–781.
21. Buckert D, Dewes P, Walcher T, Rottbauer W, Bernhardt P. Intermediate-
term prognostic value of reversible perfusion deficit diagnosis by adeno-
sine CMR.
J Am Coll Cardiol Img
2013;
6
: 56–63.
22. Steel K, Broderick R, Gandla V,
et al
. Complementary prognostic
values of stress myocardial perfusion and late gadolinium enhancement
imaging in suspected coronary artery disease.
Circulation
2009;
120
:
1390–1400.
23. Bingham SE, Hachamovitch R. Incremental prognostic significance
of combined cardiac magnetic resonance imaging, adenosine stress
perfusion, delayed enhancement, and left ventricular function over pre-
imaging information for the prediction of adverse events.
Circulation
2011;
123
: 1509–1518.
24. Chareonthaitawee P, Gersh BJ, Araoz PA, Gibbons RJ. Revascularization
in severe left ventricular dysfunction: the role of viability testing.
J Am
Coll Cardiol
2005;
46
: 567–574.
25. Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola
SH. Hybernating myocardium: diagnosis and patient outcomes.
Curr
Probl Cardiol
2007;
32
: 375–410.
26. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation and assess-
ment of myocardial viability.
Circulation
2008;
117
: 103–114.
27. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viabil-
ity testing and impact of revascularization on prognosis in patients with
coronary artery disease and left ventricular dysfunction: a meta-analysis.
J Am Coll Cardiol
2002;
39
: 1151–1158.
28. Klein C, Nekolla SG, Bengel FM,
et al.
Assessment of myocardial
viability with contrast-enhanced magnetic resonance imaging: compari-
son with positron emission tomography.
Circulation
2002;
105
: 162–167.
29. Shan K, Constantine G, Sivananthan M, Flamm SD. Role of cardiac
magnetic resonance imaging in the assessment of myocardial viability.
Circulation
2004;
109
: 1328–1334.
30. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed
enhancement cardiovascular magnetic resonance assessment of non-
ischaemic cardiomyopathies.
Eur Heart J
2005;
26
: 1461–174.
31. Romero J, Xue X, Gonzalez W, Garcia MJ. CMR imaging assessing
viability in patients with chronic ventricular dysfunction due to coronary
artery disease.
J Am Coll Cardiol Img
2012;
5
: 494–508.
32. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH.
Sensitivity, specificity, and predictive accuracies of various noninvasive
techniques for detecting hibernating myocardium.
Curr Probl Cardiol
2001;
26
: 147–186.
33. Maron BJ. Hypertrophic cardiomyopathy: a systemic review.
J Am Med
Assoc
2002;
287
: 1308–1320.
34. Olivotto I, Maron MS, Autore C,
et al
. Assessment and significance of
left ventricular mass by cardiovascular magnetic resonance in hyper-
trophic cardiomyopathy.
J Am Coll Cardiol
2008;
52
: 559–566.
35. Green JJ, Berger JS, Kramer CM, Salerno M. Prognostic value of late
gadolinium enhancement in clinical outcomes for hypertrophic cardio-
myopathy.
J Am Coll Cardiol Img
2012;
5
: 370–377.
36. Abdel-Aty H, Cocker M, Strohm O, Filipchuk N, Friedrich MG.
Abnormalities in T2-weighted cardiovascular magnetic resonance imag-
es of hypertrophic cardiomyopathy: regional distribution and relation
to late gadolinium enhancement and severity of hypertrophy.
J Magn
Reson Img
2008;
28
: 242–245.
37. Assomull RG, Prasad SK, Lyne J,
et al
. Cardiovascular magnetic
resonance, fibrosis and prognosis in dilated cardiomyopathy.
J Am Coll
Cardiol
2006;
48
: 1977–1985.
38. Wu KC, Weiss RG, Thiemann DR,
et al.
Late gadolinium enhancement
by cardiovascular magnetic resonance heralds an adverse prognosis in
nonischemic cardiomyopathy.
J Am Coll Cardiol
2008;
51
: 2414–2421.
39. McCrohon JA, Moon JC, Prasad SK,
et al
. Differentiation of heart fail-
ure related to dilated cardiomyopathy and coronary artery disease using
